Home > Boards > Free Zone > Penny Trading - Technical > BB's Stock Haven

LiveWire Ergogenics Retains Experts to Assist Company in

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Rocketstocks Member Profile
Member Level 
Followed By 958
Posts 56,545
Boards Moderated 5
Alias Born 01/22/06
160x600 placeholder
Rocketstocks Member Level  Wednesday, 02/21/18 11:02:08 AM
Re: Rocketstocks post# 4254347
Post # of 4268782 
LiveWire Ergogenics Retains Experts to Assist Company in Obtaining Cannabis Licenses and Permits

Anaheim, CA, Feb. 21, 2018 (GLOBE NEWSWIRE) -- LiveWire Ergogenics, Inc. (OTC: LVVV), which focuses on research partnerships, product development, acquisition, and management of turnkey production facilities for cannabis-based products and services, has retained the services of the Law Offices of Omar Figueroa as well as development firm Cushman Greenfield. Both companies will be working together to assist LiveWire in identifying and obtaining licenses, permits and other authorizations required by various California state and local governments to allow LiveWire to engage in cannabis activities permitted by California state law.

A pioneering cannabis lawyer, Omar Figueroa is also the author of “Cannabis Codes of California,” the first comprehensive guide to the laws and regulations that govern the California cannabis industry. Known for his ability to think outside the box and solve complex problems in novel ways, Mr. Figueroa will be working with LiveWire Ergogenics in the areas of permitting, licensing and regulatory compliance; business law; intellectual property; and legal education.

Cushman Greenfield is a well-regarded development firm specializing in license application and procurement in the medical cannabis industry. In addition to helping LiveWire navigate various license applications, they will also be providing expert advice in the areas of business development, brand development and government affairs.

“We have chosen to work with Omar Figueroa and Cushman Greenfield because these are two of the top organizations in their fields,” states Bill Hodson, LiveWire’s CEO. “Their expertise will be a significant asset to us both immediately and as our business grows. This is another valuable addition to our team.”

For more information about LiveWire Ergogenics, visit For non-material updates, follow LiveWire Ergogenics on Twitter @livewireLVVV.

About LiveWire Ergogenics, Inc.
LiveWire Ergogenics, Inc. (LVVV) specializes in identifying and monetizing current and future trends in the health and wellness industry. The Company is currently focused on establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for human and veterinarian applications. This includes the cloning of cannabis strains to produce positive medicinal results, dosing verification of zero pesticide products for quality brands, and development and licensing of high-quality cannabinoid-based products and services. The team at LiveWire Ergogenics has a passion for research and is committed to generating and implementing innovative ideas and producing high-quality products that satisfy an increasing demand in this fast-growing industry.

Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, financial projections, statements regarding the plans and objectives of management for future operations, the development, regulatory approvals and commercialization of the Company’s products, or any of the Company’s other proposed products, systems or services.

Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and actual events may differ considerably. Factors that may cause actual results to differ materially from any projections may include, without limitation, the Company’s inability to obtain additional financing, delays in the development of its products, the impact of significant government regulation in the cannabis industry, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure to implement the Company’s business plans or strategies. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.

EquiNet, LLC
Toll free: 877-964-6463
Direct: 858-264-6500

1600 North Kraemer Blvd.
Anaheim, CA 92806

My messages contain many opinions. Please do your own research
and validation.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist